JXC-11042-32536
4 vaccinations
1 coded response
41 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 852 / AZ
- Registered
- 2021-03-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-22
Dose 1 — Pfizer-BioNTech
-
2021-03-24
Registered in v-safe
- 2021-03-24
- 2021-03-25
- 2021-03-26
- 2021-03-27
- 2021-03-28
- 2021-03-29
- 2021-04-05
- 2021-04-12
-
2021-04-13
Dose 2 — Pfizer-BioNTech
-
2021-04-13
Health check-in — day 0, dose 2Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-04-14
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Fatigue or tiredness, Diarrhea, Abdominal pain · Be unable to workAdult check-in
- 2021-04-15
- 2021-04-16
- 2021-04-17
- 2021-04-19
- 2021-04-20
- 2021-04-27
- 2021-05-04
- 2021-05-11
- 2021-05-18
- 2021-05-25
- 2021-07-13
- 2021-10-12
-
2021-11-30
Dose 3 — Pfizer-BioNTech
- 2021-12-19
- 2021-12-21
- 2021-12-28
- 2022-01-04
- 2022-01-11
-
2022-03-01
Survey response — 3 months, dose 3MedDRA: Abortion spontaneous — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, HospitalizationFree text: Pregnancy lossMedDRA releases: 2024-11 · check-in free text available
-
2022-03-01
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · Hospitalization · 1 call case(s)
- 2022-03-17
- 2022-05-31
-
2022-09-28
Dose 4 — ModernaCo-administered: Flu
- 2022-09-30
- 2022-10-01
- 2022-10-02
- 2022-10-04
- 2022-10-05
- 2022-10-12
- 2022-10-19
- 2022-10-26
- 2022-11-02
- 2022-11-09
- 2022-12-28
- 2023-03-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-22 | Pfizer-BioNTech | |
| 2 | 2021-04-13 | Pfizer-BioNTech | |
| 3 | 2021-11-30 | Pfizer-BioNTech | No |
| 4 | 2022-09-28 | Moderna | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-03-01 | Unsuccessful |
Free text
Release 11 — 3 months, dose 3
Symptoms: Pregnancy loss
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release